Literature DB >> 15698511

Squamous cell carcinoma of the lower lip: FAS/FASL expression, lymphocyte subtypes and outcome.

P Somma1, L Lo Muzio, G Mansueto, M Delfino, G Fabbrocini, M Mascolo, C Mignogna, M Di Benedetto, F Carinci, A De Lillo, L Pastore, R Serpico, G De Rosa, S Staibano.   

Abstract

Squamous cell carcinoma (SCC) of the lip is a relatively common malignancy of the head and neck region. Tumour thickness, grading and perineural invasion are significant prognostic indicators. However, there is still the need of new reliable biological markers able to predict the prognosis of the single cases with an unfavourable biological behaviour unpredictable by the classic clinical-pathological parameters. 32 cases of (SCC) of the lower lip were analysed for their clincopathologic features, and immunohistochemical expression of Fas/FasL in neoplastic cells and in inflammatory infiltrate. Moreover the density and phenotype of tumour-infiltrating lymphocytes (TIL) were analysed. The results were related with the follow-up of the patients ranging from 2 to 6 years. The cases with over-expression of Fas/FasL in neoplastic cells and Fas+ in T cells preferentially showed a more aggressive clinical behaviour (P<0.01). Moreover we found an alteration of the normal expression of CD4 and CD8 lymphocyte types in ten cases. This data suggest that the Fas/FasL pathway is involved in the close relation between neoplastic cells and T cells and so in the biological behaviour of these tumours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698511     DOI: 10.1177/039463200501800107

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  2 in total

Review 1.  The role of CD95 and CD95 ligand in cancer.

Authors:  M E Peter; A Hadji; A E Murmann; S Brockway; W Putzbach; A Pattanayak; P Ceppi
Journal:  Cell Death Differ       Date:  2015-02-06       Impact factor: 15.828

2.  Oral health status and cardiovascular risk profile in Cameroonian military population.

Authors:  W Bell Ngan; L Essama Eno Belinga; Sap Essam Nlo'o; E Abeng Mbozo'o; E Otsomoti; J Mekoulou Ndongo; Ec Bika Lele; D Hupin; S H Mandengue; F Roche; B Bongue
Journal:  AIMS Public Health       Date:  2021-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.